CureApp
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | JPY3.0m | Early VC | |
JPY30.0m | Seed | ||
JPY70.0m | Seed | ||
JPY380m | Series A | ||
JPY1.5b | Series B | ||
$20.3m | Series C | ||
JPY2.1b | Series D | ||
* | JPY7.0b | Series G | |
Total Funding | $106m |
Recent News about CureApp
EditCureApp is a pioneering company in the digital therapeutics market, focusing on providing innovative treatment solutions that leverage technology to deliver personalized, evidence-based interventions. The company primarily serves patients who require cognitive and behavioral changes, offering remote treatment options that can be accessed from home or outside business hours. CureApp operates in the healthcare sector, targeting a niche market that seeks high-quality medical care without the constraints of physical limitations. The business model revolves around developing and distributing digital therapeutic applications that generate revenue through subscriptions and partnerships with healthcare providers. By integrating technology with medical expertise, CureApp aims to solve social issues in healthcare and deliver ideal medical care to a broad audience.
Keywords: digital therapeutics, personalized treatment, cognitive changes, behavioral changes, remote healthcare, evidence-based, healthcare technology, subscription model, medical care, innovation.